150 related articles for article (PubMed ID: 37955597)
1. Reversing dabigatran effect with idarucizumab to enable intravenous thrombolysis in patients with acute ischaemic stroke - a single centre experience.
Włodarczyk E; Sawczyńska K; Wrona P; Słowik A
Neurol Neurochir Pol; 2023; 57(6):465-476. PubMed ID: 37955597
[TBL] [Abstract][Full Text] [Related]
2. Intravenous Thrombolysis in Patients with Acute Ischemic Stroke after a Reversal of Dabigatran Anticoagulation with Idarucizumab: A Real-World Clinical Experience.
Šaňák D; Jakubíček S; Černík D; Herzig R; Kunáš Z; Mikulík R; Ostrý S; Reif M; Rohan V; Tomek A; Veverka T
J Stroke Cerebrovasc Dis; 2018 Sep; 27(9):2479-2483. PubMed ID: 29807757
[TBL] [Abstract][Full Text] [Related]
3. Intravenous Thrombolysis After Idarucizumab Application in Acute Stroke Patients-A Potentially Increased Sensitivity of Thrombi to Lysis?
Pretnar Oblak J; Sabovic M; Frol S
J Stroke Cerebrovasc Dis; 2019 Mar; 28(3):768-773. PubMed ID: 30527792
[TBL] [Abstract][Full Text] [Related]
4. Revascularization outcomes following acute ischemic stroke in patients taking direct oral anticoagulants: a single hospital cohort study.
Frol S; Šabovič M; Popovič KŠ; Oblak JP
J Thromb Thrombolysis; 2021 Jan; 51(1):194-202. PubMed ID: 32506363
[TBL] [Abstract][Full Text] [Related]
5. Idarucizumab for Intravenous Thrombolysis and Endovascular Thrombectomy in Acute Stroke: A Case Report.
Lin YT; Lai YJ; Lai TH
J Emerg Med; 2020 Mar; 58(3):e113-e116. PubMed ID: 31744711
[TBL] [Abstract][Full Text] [Related]
6. Idarucizumab in Dabigatran-Treated Patients with Acute Ischemic Stroke Receiving Thrombolytic Therapy.
Kikule I; Baborikina A; Haritoncenko I; Karelis G
Medicina (Kaunas); 2022 Sep; 58(10):. PubMed ID: 36295516
[No Abstract] [Full Text] [Related]
7. Intravenous Thrombolysis in Acute Ischemic Stroke After Idarucizumab Reversal of Dabigatran Effect: Analysis of the Cases From Taiwan.
Fang CW; Tsai YT; Chou PC; Chen HM; Lu CM; Tsao CR; Chen CL; Sun MC; Shih YS; Hsieh CY; Chen LA; Chen PL; Yeh JT; Li YH
J Stroke Cerebrovasc Dis; 2019 Mar; 28(3):815-820. PubMed ID: 30573284
[TBL] [Abstract][Full Text] [Related]
8. Successful intravenous thrombolysis for ischemic stroke after reversal of dabigatran anticoagulation with idarucizumab: a case report.
Agosti S; Casalino L; Rocci E; Zaccone G; Rota E
J Med Case Rep; 2017 Aug; 11(1):224. PubMed ID: 28806993
[TBL] [Abstract][Full Text] [Related]
9. Antagonizing dabigatran by idarucizumab in cases of ischemic stroke or intracranial hemorrhage in Germany - A national case collection.
Kermer P; Eschenfelder CC; Diener HC; Grond M; Abdalla Y; Althaus K; Berrouschot J; Cangür H; Daffertshofer M; Edelbusch S; Gröschel K; Haase CG; Harloff A; Held V; Kauert A; Kraft P; Lenz A; Müllges W; Obermann M; Partowi S; Purrucker J; Ringleb PA; Röther J; Rossi R; Schäfer N; Schneider A; Schuppner R; Seitz RJ; Szabo K; Wruck R
Int J Stroke; 2017 Jun; 12(4):383-391. PubMed ID: 28494694
[TBL] [Abstract][Full Text] [Related]
10. Idarucizumab Reversal of Dabigatran in Patients with Acute Ischemic Stroke and Intracranial Hemorrhage: Comparison with Non-idarucizumab-Treated Patients.
Frol S; Sernec LP; Hudnik LK; Šabovič M; Oblak JP
CNS Drugs; 2021 Feb; 35(2):233-242. PubMed ID: 33548038
[TBL] [Abstract][Full Text] [Related]
11. Acute Stroke Despite Dabigatran Anticoagulation Treated with Idarucizumab and Intravenous Tissue Plasminogen Activator.
Bissig D; Manjunath R; Traylor BR; Richman DP; Ng KL
J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):e102-e104. PubMed ID: 28416406
[TBL] [Abstract][Full Text] [Related]
12. Antagonizing dabigatran by idarucizumab in cases of ischemic stroke or intracranial hemorrhage in Germany-Updated series of 120 cases.
Kermer P; Eschenfelder CC; Diener HC; Grond M; Abdalla Y; Abraham A; Althaus K; Becks G; Berrouschot J; Berthel J; Bode FJ; Burghaus L; Cangür H; Daffertshofer M; Edelbusch S; Eggers J; Gerlach R; Gröschel K; Große-Dresselhaus F; Günther A; Haase CG; Haensch CA; Harloff A; Heckmann JG; Held V; Hieber M; Kauert A; Kern R; Kerz T; Köhrmann M; Kraft P; Kühnlein P; Latta J; Leinisch E; Lenz A; Leithner C; Neumann-Haefelin T; Mäurer M; Müllges W; Nolte CH; Obermann M; Partowi S; Patzschke P; Poli S; Pulkowski U; Purrucker J; Rehfeldt T; Ringleb PA; Röther J; Rossi R; El-Sabassy H; Sauer O; Schackert G; Schäfer N; Schellinger PD; Schneider A; Schuppner R; Schwab S; Schwarte O; Seitz RJ; Senger S; Shah YP; Sindern E; Sparenberg P; Steiner T; Szabo K; Urbanek C; Sarnowksi BV; Weissenborn K; Wienecke P; Witt K; Wruck R; Wunderlich S
Int J Stroke; 2020 Aug; 15(6):609-618. PubMed ID: 31955706
[TBL] [Abstract][Full Text] [Related]
13. Acute reversal of dabigatran with Idarucizumab for intravenous thrombolysis as acute stroke treatment.
Meyer D; Chu F; Derry K; Hailey L
J Clin Neurosci; 2019 Jan; 59():355-357. PubMed ID: 30309801
[TBL] [Abstract][Full Text] [Related]
14. Systemic Thrombolysis in Acute Ischemic Stroke after Dabigatran Etexilate Reversal with Idarucizumab-A Case Report.
Tireli D; He J; Nordling MM; Wienecke T
J Stroke Cerebrovasc Dis; 2017 Jul; 26(7):e123-e125. PubMed ID: 28479184
[TBL] [Abstract][Full Text] [Related]
15. Intravenous tPA (Tissue-Type Plasminogen Activator) in Patients With Acute Ischemic Stroke Taking Non-Vitamin K Antagonist Oral Anticoagulants Preceding Stroke.
Jin C; Huang RJ; Peterson ED; Laskowitz DT; Hernandez AF; Federspiel JJ; Schwamm LH; Bhatt DL; Smith EE; Fonarow GC; Xian Y
Stroke; 2018 Sep; 49(9):2237-2240. PubMed ID: 30354981
[TBL] [Abstract][Full Text] [Related]
16. Intravenous Thrombolysis With Recombinant Tissue-Type Plasminogen Activator in a Stroke Patient Receiving Dabigatran Anticoagulant After Antagonization With Idarucizumab.
Berrouschot J; Stoll A; Hogh T; Eschenfelder CC
Stroke; 2016 Jul; 47(7):1936-8. PubMed ID: 27301937
[TBL] [Abstract][Full Text] [Related]
17. Dabigatran initiation in patients with non-valvular AF and first acute ischaemic stroke: a retrospective observational study from the SITS registry.
Escudero-Martinez I; Mazya M; Teutsch C; Lesko N; Gdovinova Z; Barbarini L; Fryze W; Karlinski M; Kobayashi A; Krastev G; Paiva Nunes A; Pasztoova K; Peeters A; Sobolewski P; Vilionskis A; Toni D; Ahmed N;
BMJ Open; 2020 May; 10(5):e037234. PubMed ID: 32434935
[TBL] [Abstract][Full Text] [Related]
18. Idarucizumab in Dabigatran-Treated Patients with Acute Ischemic Stroke Receiving Alteplase: A Systematic Review of the Available Evidence.
Pikija S; Sztriha LK; Sebastian Mutzenbach J; Golaszewski SM; Sellner J
CNS Drugs; 2017 Sep; 31(9):747-757. PubMed ID: 28808918
[TBL] [Abstract][Full Text] [Related]
19. Dabigatran Reversal With Idarucizumab Preceding Thrombolysis in an Octogenarian Patient with Chronic Kidney Disease and Acute Stroke: A Case Report.
Laxamana LC; Co COC; Yu JRT; Mojica CV; Iboleon-Dy MAM; Domingo AMC; Ilano KCS; Macrohon-Valdez MCZ
Clin Ther; 2020 Sep; 42(9):1840-1845. PubMed ID: 32778345
[TBL] [Abstract][Full Text] [Related]
20. Successful thrombolytic therapy with recombinant tissue plasminogen activator in ischemic stroke after idarucizumab administration for reversal of dabigatran: a case report.
Ohtani T; Sintoku R; Yajima T; Kaneko N
J Med Case Rep; 2019 Dec; 13(1):390. PubMed ID: 31875786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
